Design, Rationale and Initial Findings From HERA‐FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11‐Year Period
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033396 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Christian Salbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Registries, Emergency Service, Hospital. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
For the majority of patients with atrial fibrillation (AF), disease management has improved in recent years. However, there are still populations underrepresented or excluded in current registries and randomized controlled trials. HERA‐FIB (Heidelberg Registry of Atrial Fibrillation) was planned to assess real‐world evidence for the prevalence, demographic characteristics and management of patients with the diagnosis of AF presenting consecutively to a chest pain unit. Methods and Results HERA‐FIB is a retrospective, observational, single‐center study on patients with a diagnosis of AF presenting to a chest pain unit from June 2009 until March 2020. This article describes the structure, governance, outcome assessment, quality and data collection processes of the registry. Additionally, characteristics of populations of special interest are described. The study consecutively enrolled 10 222 patients presenting with AF to the chest pain unit of the University Hospital of Heidelberg. Clinical parameters and patient characteristics were assessed retrospectively. Outcome parameters included rates for all‐cause death, stroke, myocardial infarction and major bleedings. We were able to investigate patient cohorts of special interest such as advanced chronic kidney disease, octogenarians, and those with acute coronary syndrome who are often underrepresented in current studies and randomized controlled trials.
Conclusions
HERA‐FIB is one of the largest real‐world single‐center retrospective registries on patients with AF, which captures the era of transition from vitamin K antagonists to non–vitamin K oral anticoagulation regimens in clinical practice and offers the possibility to investigate patient populations usually underrepresented or excluded in current available randomized controlled trials and registries. Registration URL: https://www.clinicaltrials.gov ; unique identifier: NCT05995561.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg Germany.
ORCID-Profile: Christian Salbach, Moritz Biener, Norbert Frey, Hugo A Katus, Evangelos Giannitsis, Barbara Ruth Milles
Zitieren
APA
Salbach, C., Yildirim, M., Hund, H., Biener, M., Müller-Hennessen, M., Frey, N., Katus, H. A., Giannitsis, E., & Milles, B. R. (2024). Design, Rationale and Initial Findings From HERA‐FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11‐Year Period. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033396
Vancouver
Salbach C, Yildirim M, Hund H, Biener M, Müller-Hennessen M, Frey N, et al. Design, Rationale and Initial Findings From HERA‐FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11‐Year Period. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033396
BibTeX
@article{Salbach2024,
author = {Salbach, Christian and Yildirim, Mustafa and Hund, Hauke and Biener, Moritz and Müller-Hennessen, Matthias and Frey, Norbert and Katus, Hugo A and Giannitsis, Evangelos and Milles, Barbara Ruth},
title = {Design, Rationale and Initial Findings From HERA‐FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11‐Year Period},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033396}
}
EUVIMED